Market Value184,674,320
Total Holdings54
File Date2023-11-08
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ILMN / Illumina, Inc.
CNC / Centene Corporation
ELV / Elevance Health, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
DHR / Danaher Corporation
TGTX / TG Therapeutics, Inc.
SPPI / Spectrum Pharmaceuticals, Inc. Call
ENSG / The Ensign Group, Inc.
SAGE / Sage Therapeutics, Inc.
PBYI / Puma Biotechnology, Inc.
XRAY / DENTSPLY SIRONA Inc.
CTRE / CareTrust REIT, Inc.
AERI / Aerie Pharmaceuticals Inc
MDGL / Madrigal Pharmaceuticals, Inc.
QGEN / Qiagen N.V.
RDUS / Radius Recycling, Inc.
KIDS / OrthoPediatrics Corp.
FATE / Fate Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ZGNX / Zogenix Inc
SPNE / SeaSpine Holdings Corp
DERM / Journey Medical Corporation
FOMX / Foamix Pharmaceuticals Ltd. Put
US0909311062 / BioSpecifics Technologies Corp.
US00C4U1L353 / Mylan N.V.
US00C4U1L353 / Mylan N.V. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TSRO / TESARO, Inc.
EPESR / Epizyme Inc
ALBO / Albireo Pharma Inc
NLTX / Neoleukin Therapeutics, Inc.
AR2 / Array Biopharma Inc.
FOMX / Foamix Pharmaceuticals Ltd.
ARQL / ArQule, Inc.
OPNT / Opiant Pharmaceuticals Inc
ABMD / Abiomed Inc.
TCDA / Tricida Inc
GHDX / Genomic Health, Inc.
IVC / Invacare Corp.
SNY / Sanofi - Depositary Receipt (Common Stock)
ABT / Abbott Laboratories
ARGX / argenx SE - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
DRNA / Dicerna Pharmaceuticals Inc
PODD / Insulet Corporation
ARNA / Arena Pharmaceuticals Inc
VKTX / Viking Therapeutics, Inc.
SPPI / Spectrum Pharmaceuticals, Inc. Put
DVAX / Dynavax Technologies Corporation
ISEE / IVERIC bio Inc
ANAB / AnaptysBio, Inc.
AGTC / Applied Genetic Technologies Corp
MDCO / Medicines Company
LOXO / Loxo Oncology, Inc.
CFMS / Conformis Inc.
TLGT / Teligent Inc
MDT / Medtronic plc
SRPT / Sarepta Therapeutics, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
AFMD / Affimed N.V.
CBAY / CymaBay Therapeutics, Inc.
LAB / Standard BioTools Inc.
CEMP / Cempra, Inc.
IOVA / Iovance Biotherapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
NTRA / Natera, Inc.
98235T107 / Wright Medical Group N.V.
MRK / Merck & Co., Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
MODN / Model N, Inc.
RCM / R1 RCM Inc.
IMUX / Immunic, Inc. Put
SPY / SPDR S&P 500 ETF Put
FOLD / Amicus Therapeutics, Inc.